Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Centessa Pharmaceuticals plc ADR’s stock clocked out at $16.83, up 4.53% from its previous closing price of $16.10. In other words, the price has increased by $4.53 from its previous closing price. On the day, 0.57 million shares were traded. CNTA stock price reached its highest trading level at $17.09 during the session, while it also had its lowest trading level at $15.28.
Ratios:
To gain a deeper understanding of CNTA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when SAHA SAURABH sold 32,023 shares for $18.28 per share. The transaction valued at 585,419 led to the insider holds 630,661 shares of the business.
SAHA SAURABH bought 32,023 shares of CNTA for $585,418 on Nov 13 ’24. On Oct 25 ’24, another insider, Weinhoff Gregory M, who serves as the Chief Business Officer of the company, sold 11,742 shares for $15.38 each. As a result, the insider received 180,628 and left with 183,266 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2218951424 and an Enterprise Value of 1428938880. For the stock, the TTM Price-to-Sale (P/S) ratio is 320.67 while its Price-to-Book (P/B) ratio in mrq is 4.44. Its current Enterprise Value per Revenue stands at 208.513 whereas that against EBITDA is -8.859.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $18.74, while it has fallen to a 52-week low of $5.58. The 50-Day Moving Average of the stock is 5.39%, while the 200-Day Moving Average is calculated to be 43.15%.
Shares Statistics:
It appears that CNTA traded 639.82K shares on average per day over the past three months and 730240 shares per day over the past ten days. A total of 98.77M shares are outstanding, with a floating share count of 89.08M. Insiders hold about 32.34% of the company’s shares, while institutions hold 51.12% stake in the company. Shares short for CNTA as of 1730332800 were 2147348 with a Short Ratio of 3.36, compared to 1727654400 on 1956095. Therefore, it implies a Short% of Shares Outstanding of 2147348 and a Short% of Float of 2.0599999.
